Regular aspirin use may protect against bile duct cancer

Regular aspirin use may protect against bile duct cancer

(HealthDay)—Regular aspirin use may lower the risk of bile duct cancer, according to a study published online April 26 in Hepatology.

The study included 2,395 bile duct cancer patients and a control group of 4,769 individuals without the cancer. About 25 percent of the bile duct cancer patients and 45 percent of those in the took aspirin.

The authors found that, overall, people who took aspirin were roughly three times less likely to develop bile duct cancer than those who did not take aspirin. The findings do not prove that aspirin caused the risk of bile duct cancer to drop. However, "chronic persistent inflammation is one of the key elements that promotes cancer of the bile ducts, and well-known risk factors for bile duct cancer have all been shown to increase the risk for cancer by inducing of the ducts," study coauthor Jonggi Choi, M.B., Ch.B., Ph.D., of the Mayo Clinic College of Medicine in Rochester, Minn., said in a journal news release.

The findings suggest that further research on the potential for aspirin to prevent is warranted, the study authors said.

Explore further

Aspirin use may help prevent bile duct cancer, study finds

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Hepatology

Copyright © 2016 HealthDay. All rights reserved.

Citation: Regular aspirin use may protect against bile duct cancer (2016, May 9) retrieved 20 July 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more